CGEM
Cullinan Oncology (CGEM)
$60
About Cullinan Oncology (CGEM)
Cullinan Therapeutics, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Details
Daily high
$11.86
Daily low
$10.78
Price at open
$10.86
52 Week High
$30.19
52 Week Low
$9.24
Market cap
675.4M
Dividend yield
0.00%
Volume
875,853
Avg. volume
536,274
P/E ratio
-4.03
Cullinan Oncology News
Details
Daily high
$11.86
Daily low
$10.78
Price at open
$10.86
52 Week High
$30.19
52 Week Low
$9.24
Market cap
675.4M
Dividend yield
0.00%
Volume
875,853
Avg. volume
536,274
P/E ratio
-4.03